drugset / Trial / NCT03331861

Metformin in Heart Failure Without Diabetes

NCT03331861 ↗

Phase 2 Terminated 6 enrolled Columbia University
RandomizedParallel-groupQuadruple-blindTreatment

Summary

A pilot clinical research study that will assess the use of the medication metformin for heart failure in patients who are not diabetic and have no evidence of insulin resistance.

Timeline

Start
2019-02-15
Primary completion
2021-08-20
Completion
2021-08-20

Outcome

Outcome not reported

Stopped (Business): “Lack of funding”

Drugs

EvaluationDrugModalityDoseRoute
Subject Metformin Small molecule 1000 mg —

Indications